July 2026
The global in-silico drug discovery market size is estimated to hit around USD 11.8 billion by 2035 increasing from USD 4.17 billion in 2025, with a CAGR of 10.96%.
September 2026
The artificial intelligence (AI) in drug discovery market size is predicted to surpass around USD 17.81 billion by 2035 from USD 7.62 billion in 2026 with a solid CAGR of 9.90%.
September 2026
The global drug discovery outsourcing market size was valued at USD 4.78 billion in 2026 and is projected to hit around USD 8.98 billion by 2035 with a CAGR of 7.27%.
September 2026
The global drug discovery market size was evaluated at USD 78.51 billion in 2026 and is projected to hit around USD 171.36 billion by 2035 with a CAGR of 9.07%.
September 2026
The drug discovery services market size was estimated at USD 27.89 billion in 2026 and is expected to hit around USD 89.58 billion by 2035, growing at a CAGR of 13.95% from 2026 to 2035.
September 2026
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
September 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.83 billion in 2026, with a CAGR of 9.70%.
September 2026
The computational medicine and drug discovery software market size reached USD 12.94 billion in 2026, with leading computational medicine and drug discovery software market companies including Entelos Inc., Crown Bioscience Inc., Chemical Computing Group Inc., Nimbus Therapeutics Inc.
September 2026
The U.S. drug discovery market generated USD 28.66 billion in 2026, with prominent U.S. drug discovery market companies including Johnson and Johnson, Pfizer Inc., Merck and Co.
September 2026
The CNS drug discovery market was valued at USD 10.86 billion in 2026, with leading companies including Eli Lilly and Company, Roche, Novartis, Pfizer, AbbVie.
September 2026
The drug discovery informatics market size stood at USD 5.35 billion in 2026, with major drug discovery informatics companies including collaborative drug discovery inc, eurofins discoverx products, jubilant biosys, selvita, novo informatics pvt ltd.
May 2026
The global large molecule drug discovery outsourcing market size was evaluated at USD 3.20 billion in 2025 and is predicted to hit around USD 7.67 billion by 2035, growing at a CAGR of 9.14%.
March 2026
The global computer-aided drug discovery market size is projevted to hit around USD 14.38 billion by 2035 from USD 4.72 billion in 2025 with a CAGR of 11.78%.
January 2026
The global small molecule drug discovery market size is calculated at USD 95.63 billion in 2025 and is projected to hit around USD 204.06 billion by 2035 with a CAGR of 7.87%.
January 2026
The generative AI in drug discovery market size reached USD 260.56 million in 2025 and is estimated to hit around USD 2,724.15 million by 2035, at a CAGR of 26.45%.
September 2026
The pharma 4.0 market was valued at USD 23.16 billion in 2026, with leading companies including Matthews Specialty Vehicles, Farber Specialty Vehicles, Medical Coaches.
September 2026
The quantum computing in healthcare market was valued at USD 414.14 million in 2026, with leading companies including IBM, Microsoft, Google.
September 2026
The fetal bovine serum market was valued at USD 2.73 billion in 2026, with leading companies including TCS Biosciences Ltd, Merck KGaA, Gemini Bio-Products.
September 2026
The global general anesthesia drugs market size was calculated at USD 5.81 billion in 2026 and is projected to surpass around USD 8.06 billion by 2035, with a CAGR of 3.71%.
September 2026
The global critical care drugs market size was evaluated at USD 1.28 billion in 2026 and is projected to surge around USD 2.00 billion by 2035, with a CAGR of 5.07%.
September 2026
The global expectorant drugs market size was evaluated at USD 19.56 billion in 2026 and is predicted to hit around USD 29.72 billion by 2035, growing at a CAGR of 4.76%.
September 2026
The global terbinafine hydrochloride drug market size was evaluated at USD 1.59 billion in 2026 and is predicted to hit around USD 3.43 billion by 2035, growing at a CAGR of 8.92%.
September 2026
The global antitussive drugs market size was evaluated at USD 1.81 billion in 2026 and is predicted to hit around USD 2.86 billion by 2035, growing at a CAGR of 5.23%.
September 2026
The global PD-1 inhibitor drugs market size was estimated at USD 56.29 billion in 2026 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
September 2026
The injectable drug delivery market reached USD 829.98 billion in 2026, with prominent companies such as Sandoz, therumo, schott ag, gerresheimer, ypsormed leading the injectable drug delivery market.
September 2026
The advanced drug delivery market size is calculated at USD 103.84 billion in 2026 and is projected to hit around USD 371.83 billion by 2035 with a CAGR of 15.26%.
September 2026
The global erectile dysfunction drugs market size was estimated at USD 2.93 billion in 2024 and is predicted to be worth around USD 6.74 billion by 2034, with a CAGR of 8.69%.
September 2026
The global epigenetics drugs and diagnostic technologies market size is estimated to hit around USD 79.03 billion by 2035 increasing from USD 23.13 billion in 2026, with a CAGR of 14.63%.
September 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
September 2026
The liver cancer drug market was valued at USD 5.19 billion in 2026, with leading companies including Bayer AG, Bristol Myers Squibb.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com